Health Condition 1: D899- Disorder involving the immune mechanism, unspecified Health Condition 2: K137- Other and unspecified lesions of oral mucosa
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Clinically symptomatic and histologically proven cases of oral lichen planus in accordance to WHO criteria. 2)Patient who give written consent to participate in the study
Exclusion criteria
Exclusion criteria: )Patient under the age of 18 years. 2)Histopathological signs of moderate to severe dysplasia. 3)Patients with genital or cutaneous involvement. 4)History of topical or systemic corticosteroids therapy within one month prior to recruitment. 5)Allergic or contraindication to administration of injectable corticosteroids. 6)Patients with Hb levels 7)Patients with known hematological disease, chronic liver disease and psychiatric disorders. 8)Smokers or chewable tobacco users. 9)Patients with pregnancy or lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To evaluate and compare the size of lesion in both the groups. 2)To evaluate and compare the healing of lesion after the treatment in both the groups Timepoint: 1)BASELINE,1 MONTH, 6 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| )Change in intensity of pain score. 2)To assess patient satisfaction. 3)To evaluate the need of alternative treatment modalities. 4) To evaluate the side effects of injectable platelet rich fibrin, if any Timepoint: baseline, 1month,3months,6months | — |
Countries
India
Contacts
PGIDS, Rohtak